UNSPSC 51121583: Propafenone hydrochloride

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C21H27NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33XCH0HOCD, chemically known as 1-propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl- but more generally known as propafenone hydrochloride, which bears US NIH Compound Identifier 4932. European Medicines Agency schedules Propafenone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04077MIG.

UNSPSC 51121583 Propafenone hydrochloride is a Commodity code covering prescription cardiac medications supplied to state and local emergency medical services and healthcare systems. Recent state and local procurement activity under this code reflects purchasing of Advanced Life Support medications by fire rescue departments and emergency services for prehospital and acute-care settings. Issuing bodies include municipal fire departments and city purchasing offices acting on behalf of emergency medical services operations. The scope of work encompasses supply of branded or generic formulations meeting USP or equivalent standards, with strict expiration-date requirements (typically nine months or more from acceptance), warranty coverage against defects, and expedited delivery windows (ten calendar days or faster). Vendors must provide Safety Data Sheets compliant with OSHA Hazard Communication Standards and demonstrate accessibility conformance to WCAG 2.2 Level AA and Section 508 standards where required. Small Local Business Enterprise set-asides and bid discounts appear in municipal solicitations in this space.

The City of Tampa's Purchasing Department issued an IFB (Bid No. 26-P-00188) for Advanced Life Support Medications for Tampa Fire Rescue on April 24, 2026, with a response deadline of April 8, 2026 and an estimated contract value of $40,000. The solicitation specified four cardiac and vasopressor medication line items (Labetalol HCI, Epinephrine 1:10,000, Adenosine, and Diltiazem) with firm pricing inclusive of freight on board to Tampa, Florida. The contract term was one year with two one-year renewal options plus unilateral extension rights for up to three 30-day periods. Award was to be made to the lowest responsive, responsible bidder within 120 days of bid opening. The SLBE sheltered-market designation included a 5 percent bid discount not to exceed $10,000. Recent activity is concentrated in Florida, with Tampa as an identifiable repeat buyer in emergency medical services procurement.